In 2004, the company hit multiyear highs as it became clear that it would dominate the field of drug-coated stents, coils of metal mesh that are used to prop open clogged arteries.

FORBES: J&J Walks Away

It will probably take it two years to come out with a drug-coated device, leaving the field to only two players.

FORBES: Boston Scientific Close On J&J's Heels With New Stent